StudyRareStudyRare
Log in to add personal notes on this page.

A patient with a spontaneous pneumothorax has numerous skin-colored papules on the face and neck (fibrofolliculomas). Imaging reveals bilateral renal tumors.

AD; FLCN (folliculin, a tumor suppressor); loss of function, with somatic loss of the second copy in renal tumors

Folliculin is a ubiquitously expressed tumor suppressor that acts as a cytoplasmic guanine exchange factor. With its partners FNIP1 and FNIP2 it is recruited to the lysosome when amino acids are scarce, and there it controls amino acid-dependent activation of mTOR. It also has roles in ciliogenesis, autophagy, and lysosome biogenesis.

BHD is loss of function. Most germline variants truncate the protein, and 20% to 24% of families carry the loss or gain of one C in the polycytosine tract of exon 11 (c.1285delC or c.1285dupC), a mutational hot spot. Renal tumors, which develop in 15% to 30% of carriers, show somatic inactivation of the remaining copy, and folliculin loss upregulates mTOR. The tumors are most often hybrid oncocytic or chromophobe, and they are usually indolent, so lesions under 3 cm are watched.

Penetrance is very high: up to 97% of carriers develop at least one feature (fibrofolliculomas, lung cysts with pneumothorax, renal tumors). Genotype-phenotype correlations are preliminary. The two exon 11 hot spot variants may carry a lower renal tumor frequency, and c.1285dupC a higher risk of colorectal neoplasia. The common Smith-Magenis syndrome deletion removes one FLCN copy, so those patients carry the first hit.

  • Fibrofolliculomas (skin lesions - face, neck)
  • Pulmonary cysts → spontaneous pneumothorax
  • Renal tumors (chromophobe RCC, oncocytoma, hybrid)
  • Bilateral/multifocal renal tumors
  • Clinical suspicion from the dermatologic-pulmonary-renal triad: multiple fibrofolliculomas, basally located lung cysts with spontaneous pneumothorax, and bilateral/multifocal renal tumors
  • Renal tumors are characteristically chromophobe RCC, oncocytoma, or hybrid oncocytic/chromophobe tumors
  • Confirm with germline FLCN sequencing and deletion/duplication analysis
  • Renal surveillance with periodic abdominal MRI (preferred over CT to limit cumulative radiation); nephron-sparing surgery for tumors reaching ~3 cm
  • Counsel on pneumothorax risk: smoking cessation, caution with high-pressure activities (scuba diving), and prompt evaluation of acute dyspnea or chest pain
  • Dermatologic management of symptomatic fibrofolliculomas (benign; treated for cosmesis)
  • Cascade testing of at-risk relatives

"Bird-Hawk-Dube" syndrome, mutation in FaLCoN: Birds fly in the air, which reminds you of lung cysts and pneumothorax.

BiRRT = Bilateral Renal and Respiratory (Lung) Tumors and cysts. HOG = Hair follicle OverGrowth with fibrous tissue (fibrofolliculomas). DUBe = Dermatologic features are Usually Benign.

This table compares genetic disorders presenting with facial papules, including BHD, NF1, Cowden, TSC, nevoid basal cell carcinoma, and CYLD cutaneous syndrome.

Genetic disorders with facial papules: FLCN (BHD/fibrofolliculomas), NF1 (neurofibromas), PTEN (Cowden/trichilemmomas), TSC1/TSC2 (angiofibromas), PTCH1 (basal cell nevi), CYLD (trichoepitheliomas)
Genetic disorders with facial papules: FLCN (BHD/fibrofolliculomas), NF1 (neurofibromas), PTEN (Cowden/trichilemmomas), TSC1/TSC2 (angiofibromas), PTCH1 (basal cell nevi), CYLD (trichoepitheliomas)

Reference Links